Both in Pharmaceuticals
Zymeworks vs Vera Therapeutics
Over the past year ZYME returned +51.2% and VERA returned +21.6%; their daily moves had a correlation of 0.35.
ZYME +51.2% VERA +21.6%Growth of $1, one year, split-adjusted
| Metric | ZYME | VERA |
|---|---|---|
| Price | $28.57 | $31.54 |
| Market cap | $2.05B | $2.27B |
| Today | −0.14% | +1.81% |
| 1 month | +13.6% | +3.7% |
| 6 months | +6.7% | −11.2% |
| Year to date | +8.5% | −37.7% |
| 1 year | +49.4% | +6.3% |
| Revenue growth (YoY) | −90.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −980.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 55.3× | — |
| Net cash | $270.7M | $423.9M |
| Dividend yield | — | — |
| Volatility (60d) | 46.5% | 60.1% |
| Short % of float | 13.0% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).